More on MDWD
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $12.21 |
|
|||
| Open | $12.24 | ||||
| 52 Wk High | $10.47 | ||||
| 52 Wk Low | $5.10 | ||||
| Day High | $12.24 | ||||
| Day Low | $11.84 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 33,444 | ||||
- TD Cowen Reiterates Buy Rating on MediWound Ltd (MDWD)
- MediWound gets $3.3M more from U.S. government for NexoBrid program
- MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®
- MediWound's EscharEx Phase III study cleared to continue by safety board
- Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification
- MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Form 4 MediWound Ltd. For: Aug 26 Filed by: Hess Shmuel
- Form 144 MediWound Ltd. Filed by: Hess Shmuel
- Form SCHEDULE 13G/A MediWound Ltd. Filed by: HOLD Alapkezelo Zrt.
- Form SCHEDULE 13G/A MediWound Ltd. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Entities mentioned with MDWD
- FDA | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
